Quinolinate neurotoxicity in cortical cell culture - PubMed (original) (raw)
Quinolinate neurotoxicity in cortical cell culture
J P Kim et al. Neuroscience. 1987 Nov.
Free article
Abstract
The central neurotoxicity of the endogenous tryptophan metabolite, quinolinate, has been postulated to participate in the pathogenesis of the neuronal cell loss associated with several neurological disease states. In the present study, quinolinate neurotoxicity was quantitatively studied in dissociated cell cultures prepared from the fetal mouse neocortex. Sufficient exposure of cortical cultures to quinolinate was associated with considerable neuronal cell loss, but no glial cell loss; this neurotoxicity could be blocked by 2-amino-5-phosphonovalerate and kynurenate, drugs known to block N-methyl-D-aspartate receptors. The quinolinate dose-toxicity relationship showed that the potency of quinolinate as a neurotoxin is relatively low, especially with brief (20 min) exposure times, where an ED50 of 2 mM was observed. However, with longer exposure times of 24 and 96 h, quinolinate is more potent: the latter exposure was characterized by an ED50 of 250-400 microM. Ion substitution experiments suggested that quinolinate neurotoxicity can be separated into two distinct components on the basis of differences in time course and ionic dependence: an acute, sodium-dependent "excitotoxic" component, marked by early cell swelling; and a late, calcium-dependent component, marked by delayed cell degeneration. Acute neuronal swelling was seen only with exposure to quinolinate concentrations in excess of 1 mM, so under actual pathophysiological conditions, quinolinate neurotoxicity might be nearly completely related to the calcium-dependent component, with little or no "excitotoxic" contribution.
Similar articles
- Quinolinate and kainate neurotoxicity in neostriatal cultures is potentiated by co-culturing with neocortical neurons.
Galarraga E, Surmeier DJ, Kitai ST. Galarraga E, et al. Brain Res. 1990 Apr 2;512(2):269-76. doi: 10.1016/0006-8993(90)90636-P. Brain Res. 1990. PMID: 1972342 - L-homocysteate is a potent neurotoxin on cultured cortical neurons.
Kim JP, Koh JY, Choi DW. Kim JP, et al. Brain Res. 1987 Dec 22;437(1):103-10. doi: 10.1016/0006-8993(87)91531-9. Brain Res. 1987. PMID: 3322507 - A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro.
Burton NR, Smith DA, Stone TW. Burton NR, et al. Br J Pharmacol. 1988 Mar;93(3):693-701. doi: 10.1111/j.1476-5381.1988.tb10328.x. Br J Pharmacol. 1988. PMID: 2897220 Free PMC article. - Quinolinate is a weak excitant of cortical neurons in cell culture.
Peters S, Choi DW. Peters S, et al. Brain Res. 1987 Sep 8;420(1):1-10. doi: 10.1016/0006-8993(87)90233-2. Brain Res. 1987. PMID: 2890410 - Endogenous excitotoxic agents.
Stone TW, Connick JH, Winn P, Hastings MH, English M. Stone TW, et al. Ciba Found Symp. 1987;126:204-20. doi: 10.1002/9780470513422.ch13. Ciba Found Symp. 1987. PMID: 2884085 Review.
Cited by
- Inflammation and depression: is there a causal connection with dementia?
Leonard BE, Myint A. Leonard BE, et al. Neurotox Res. 2006 Oct;10(2):149-60. doi: 10.1007/BF03033243. Neurotox Res. 2006. PMID: 17062376 Review. - Glutaric aciduria type I and kynurenine pathway metabolites: a modified hypothesis.
Varadkar S, Surtees R. Varadkar S, et al. J Inherit Metab Dis. 2004;27(6):835-42. doi: 10.1023/B:BOLI.0000045767.42193.97. J Inherit Metab Dis. 2004. PMID: 15505390 Review. - Regulation of dopamine function in the nucleus accumbens of the rat by the thalamic paraventricular nucleus and adjacent midline nuclei.
Jones MW, Kilpatrick IC, Phillipson OT. Jones MW, et al. Exp Brain Res. 1989;76(3):572-80. doi: 10.1007/BF00248914. Exp Brain Res. 1989. PMID: 2676574 - Changes in the immune system in depression and dementia: causal or coincidental effects?
Leonard BE, Myint A. Leonard BE, et al. Dialogues Clin Neurosci. 2006;8(2):163-74. doi: 10.31887/DCNS.2006.8.2/bleonard. Dialogues Clin Neurosci. 2006. PMID: 16889103 Free PMC article. Review. - Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis.
Tan VX, Guillemin GJ. Tan VX, et al. Front Neurosci. 2019 Sep 20;13:1013. doi: 10.3389/fnins.2019.01013. eCollection 2019. Front Neurosci. 2019. PMID: 31616242 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources